
|Articles|February 1, 2004
Complementary fillers seen as future of facial rejuvenation
New York - Comparing the pros and cons of facial rejuvenation techniques such as dermal fillers, Botox, and nonablative lasers is like comparing the pros and cons of peanut butter and jelly. They are completely different products that aren't nearly as effective alone as they are together. That's what oculoplastic surgeons Stephen Bosniak, M.D., New York, and Marian Zilkha, M.D., Brazil, found in their study of FDA-approved Restylane and Perlane (pending approval).
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity
2
Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS
3
Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026
4
FDA Feedback Supports BLA Pathway for Sonelokimab in HS
5


















